Laddar populära aktier...
Asahi Kasei has reached 93%, including acquired shares.
Q2 numbers much as expected Løvmeis exploration well to be drilled in Q3 Reiterate fair value range ...
Redeye is favorable to the further validation of Nevisense in the US.
Cereno Scientific has announced its Q224 results, reflecting tangible progress with its clinical can...
Med stark krona och fortsatt restriktiv penningpolitik är utsikterna för resten av året inte särskil...
Redeye updates on Maximum Entertainment post Q2-results where topline was somewhat soft while EBITDA...
Redeye concludes that TH1NG’s reported revenues were in line with our estimates, yet the gross margi...
Redeye saw sales development that was far better than our expectations.
Redeye states that Systemair's Q1 report only offered a couple of minor surprises.
Syncro Group har publicerat koncernens delårsrapport för det andra kvartalet 2024.
Idag, fredag 30 augusti, offentliggjorde Enrad AB (”Enrad” eller ”Bolaget”) sin rapport för kv2 2024...
SmartCrafts andra kvartal visar på en fortsatt stark tillväxt i både omsättning och ARR.
Ett starkt kvartal till: Depåstoppsmodellen lyfte omsättningen kraftigt, +24%, och resultatet ökade ...
Redeye return with a research update following BioArctic's Q2 report and recent events, and largely ...
MODI reported Q2’24 sales largely in line with last year, at SEK 7.